| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Judy D. Olian is Director at MAT, with reported holdings spanning 3 companies. From May 2018 to July 2026, the filings on record show 1 open-market purchase and 18 sales. Judy D. Olian's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8.3M at current prices.
Our model assigns Judy D. Olian a middling insider score of 58/100, based on 19 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -7.8%.
Judy D. Olian's largest disclosed position is in ARES as Director, worth about $4.1M. The ARES filings lean toward selling, a net 4,137 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 5,000 | $248.20 | $1,241,006.38 | -40.6% | +11.5% | +24.4% | |
| May 23, 2023 | ARES Ares Management Corp | Director | Sell | 1,200 | $85.59 | $102,708.00 | -4.0% | +15.9% | +70.8% | |
| Jan 3, 2023 | UTHR United Therapeutics Corp | Director | Sell | 1,150 | $276.26 | $317,699.00 | -15.0% | -17.6% | -16.5% | |
| Dec 9, 2022 | UTHR United Therapeutics Corp | Director | Sell | 1,010 | $282.00 | $284,820.00 | -11.7% | -19.7% | -13.8% | |
| Nov 8, 2022 | UTHR United Therapeutics Corp | Director | Sell | 600 | $265.09 | $159,054.00 | -6.5% | -2.9% | -14.1% | |
| Jun 27, 2022 | UTHR United Therapeutics Corp | Director | Sale+OE | 10,000 | $240.34 | $2,403,439.95 | -54.9% | -15.7% | -10.8% | |
| May 26, 2022 | UTHR United Therapeutics Corp | Director | Sale+OE | 10,000 | $226.46 | $2,264,638.00 | -54.9% | -1.0% | -7.8% | |
| Apr 1, 2021 | UTHR United Therapeutics Corp | Director | Sale+OE | 4,207 | $184.96 | $778,126.72 | -42.1% | -6.7% | -4.0% | |
| Mar 17, 2021 | UTHR United Therapeutics Corp | Director | Sale+OE | 2,103 | $170.00 | $357,510.00 | -26.6% | +4.3% | +7.8% |